Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

NovaBay Pharmaceuticals Company Profile (NYSE:NBY)

Consensus Ratings for NovaBay Pharmaceuticals (NYSE:NBY) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for NovaBay Pharmaceuticals (NYSE:NBY)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/28/2014Edison Investment ResearchPositiveViewTweet This Rating  Share This Rating on StockTwits
3/6/2013Ascendiant Capital MarketsInitiated CoverageStrong-Buy$2.25ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss NovaBay Pharmaceuticals